SCHEMBL2811883

SCHEMBL2811883

COc1cccc(OC)c1OC=C(C)C(=O)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.47
TP53 P04637 2/20 0.46
CYP19A1 P11511 1/20 0.44
KCNK3 O14649 2/20 0.43
KCNK9 Q9NPC2 2/20 0.43
KMT2A Q03164 3/20 0.43
MAPK1 P28482 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43
TUBA3E Q6PEY2 1/20 0.43
TUBA1A Q71U36 1/20 0.43
TUBA1C Q9BQE3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2811877 1.00 HIF1A (0.47) HIF1ATP53CYP19A1KCNK3KCNK9
SCHEMBL3983369 0.92 HIF1A (0.48) HIF1ATP53CYP19A1KCNK3KCNK9
SCHEMBL2809083 0.89 NPSR1 (0.48) HIF1ACYP19A1KMT2AMAPK1NPSR1
SCHEMBL2809079 0.89 NPSR1 (0.48) HIF1ACYP19A1KMT2AMAPK1NPSR1
SCHEMBL2812445 0.81 CA12 (0.47) KMT2AMEN1GAAMAPTALDH1A1
SCHEMBL2812447 0.81 CA12 (0.47) KMT2AMEN1GAAMAPTALDH1A1
SCHEMBL2809730 0.80 NOTUM (0.51) KMT2ARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL2810917 0.80 SMN1; SMN2 (0.55) HIF1ATP53CYP19A1KCNK9KMT2A
SCHEMBL2809725 0.80 NOTUM (0.51) KMT2ARAB9ANPC1SMN1; SMN2MEN1
SCHEMBL2810919 0.80 SMN1; SMN2 (0.55) HIF1ATP53CYP19A1KCNK9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 HIF1A 2986/4885TP53 4572/4885CYP19A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.